Acute kidney injury in patients with decompensated heart failure

British Journal of Hospital Medicine

Volumn 71, Issue 5, 2010, Pages 269-275

  Borman, Natalie L ^a   Kalra, Philip A ^b   Kalra, Paul R ^c  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c PORTSMOUTH HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE KIDNEY INJURY; COMPLICATION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR;

ACUTE KIDNEY INJURY; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIURETICS; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; PROGNOSIS; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS;

EID: 77955971438     PISSN: 17508460     EISSN: None     Source Type: Journal    
DOI: 10.12968/hmed.2010.71.5.47907     Document Type: Review

References (42)

1. Anker SD, Sharma R (2002) The syndrome of cardiac cachexia. Int J Cardiol 85: 51-66
2. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B (2005) The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 26(1): 11-17
3. Cavalcante JL, Khan S, Gheorghiade M (2008) EVEREST study: Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan. Expert Rev Cardiovasc Ther 6(10): 1331-8
4. Cheung CM, Hegarty J, Kalra PA (2005) Dilemmas in the management of renal artery stenosis. Br Med Bull73-74: 35-55
5. CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the cooperative North Scandinavan Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429-35
6. Costanzo MR, Guglin ME, Saltzberg MT et al (2007) Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49(6): 684-6
7. Cotter G, Dittrich HC, Weatherlev BD, Bloomfield DM, O'Connor CM, Metra M, Massie BM (2008) The PROTECT pilot study. A randomized, placebo controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment. J Card Fail 14(8): 631-49
8. Cowie MR, Komajda M, Murray-Thomas T, Underwood J, Ticho B (2004) Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH). Eur Heart J 27: 1216-22
9. Damman K, Navis G, Smilde TD et al (2007) Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction. Eur J Heart Fail9: 872-8
10. De Silva R, Nikitin NP, Witte KKA et al (2005) Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis. Eur Heart J 27(5): 569-81
11. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW (2000) The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35: 681-9
12. Forman DE, Butler J, Wang Y, et al (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43: 61-7
13. Francis G (2006) Acute decompenstaed heart failure: The cardiorenal syndrome. Cleve Clin J Med 73(supp 2): S8-S13
14. Geisberg C, Butler J (2006) Addressing the challenges of cardiorenal syndrome. Cleve Clin J Med 77(5): 485-91
15. Gheorghiade M, Orlandi C, Burnett JC et al (2005) Rationale and design of the multicenter, randomized, double-blind, placebocontrolled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). J Card Fail 11: 260-9
16. Go AS, Chcrtow GM, Fan D, McCulloch CE, Hsu C (2004) Chronic kidney disease and the risk of death, cardiovascular events and hospitalization. N EnglJ Med 351(13): 1296-305
17. Gottlieb SS, Abraham W, Butler J et al (2002) The prognostic importance of different definitions of worsening renal function in congestive cardiac failure. J Card Fail 8(3): 136-41
18. Gotloib L, Fudin R, Yakubovich M, Vienken J (2005) Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation. Nephrol Dial Transplant 20(Suppl 7): 32-6
19. Heywood JT (2004) The cardiorenal syndrome: Lessons from the ADHERE database and treatment options. Heart Fail Rev 9: 195-201
20. Hillege HL, Girbes ARJ, De Kam PJ et al (2000) Renal function, neurohormonal activation and survival in patients with chronic heart failure. Circulation 102: 203-10
21. Hillege HL, Nitsch D, Pfeffer MA et al (2006) Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 113: 671-8
22. Iaina A, Silverbcrg DS, Wexler D, Iaina Nomy L (2007) The cardiorenal anemia syndrome. Med Pregl 60 (Suppl 2): 145-50
23. Ismailov RM, Goldberg RJ, Lessard D, Spencer FA (2007) Decompensated heart failure in the setting of kidney dysfunction: a community-wide perspective. Nephron Clin Pract 107: 147-55
24. Kagan A, Rapoport J (2005) The role of peritoneal dialysis in the treatment of refractory heart failure. Nephrol Dial Transplant 20(Suppl 7): 28-31
25. Kalra PA, Guo H, Kausz AT et al (2005) Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int 68(1): 293-301
26. Kalra PR, Anker AD, Coats AJ (2001) Water and sodium regulation in chronic heart failure: the role of naturetic peptides and vasopressin. Cardiovasc Res 51(3): 495-509
27. Kalra PR, Collier T, Cowie MR et al (2003) Haemoglobin concentration and prognosis in new cases of heart failure. Lancet 263(9379): 211-12
28. Kimmenade RRJ, Pinto Y, Januzzi JL (2007) When renal and cardiac insufficiencies intersect: is there a role for natriuretic peptide testing in the cardio-renal syndrome? Eur Heart J 28(4): 2960-3
29. MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamtora H, Brown K (1998) Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet 352(9121): 13-16
30. Mehrotra R, Khanna R (2001) Peritoneal ultrafiltration for chronic congestive cardiac failure: rational, evidence and future. Cardiology 96:177-82
31. Niebauer J, Volk HD, Kemp M et al (1999) Endotoxins and immune activation in chronic heart failure: A prospective cohort study. Lancet 353(9167): 1838-42
32. Packer M, Fowler MB, Roecker EB et al (2002) Effect of carvediolol on the mortality of patients with severe chronic heart failure: results of the Carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 106(17): 2194-9
33. Pitt B, Zannad F, Remme W et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341(10): 709-17
34. Ronco C, House AA, Haapio M (2008) Cardiorenal syndrome: refining the definition of a complex symbiosis gone wrong. intensive Care Med 34(5): 957-62
35. Schrier RW, Abraham WT (1999) Hormones and haemodynamics in heart failure. N Engl J Med 341(8): 577-85
36. Shlipak MG, Massie BM (2004) The clinical challenge of cardiorenal syndrome. Circulation 110: 1514-17
37. Smith GL, Vaccarino V, Kosiborod M, Lichman JH, Cheng S, Watnick SG, Krumholz HM (2003) Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9: 13-25
38. SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293-302
39. Sosnov J, Lessard D, Goldberg RJ, Yarzebski J, Gore JM (2006) Differential symptoms of acute myocardial infarction in patients with kidney disease: a community wide prospective. Am J Kidney Dis 47(3): 378-84
40. Stevenson LW, Nohria A, Mielniczuk L (2005) Torrent or torment from the tubules? Challenge of the cardiorenal connections. J Am Coll Cardiol 45(12): 2004-7
41. Yancy CW, Lopatin M, Warner Stevenson L, De Marco T, Fonarow GC (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 47: 76-84
42. Zannad F, Adamopoulos C, Mebazaa A, Gheorghiade M (2006) The challenge of acute decompensated heart failure. Heart Fail Rev 11: 135-9